Heterogeneity and coexistence of T790M and T790 wild-type resistant subclones drive mixed response to third-generation epidermal growth factor receptor inhibitors in lung cancer. Piotrowska, Z., Hazar-Rethinam, M., Rizzo, C., Nadres, B., Van Seventer, E. E, Shahzade, H. A, Lennes, I. T, Iafrate, A. J, Dias-Santagata, D., Leshchiner, I., & others JCO precision oncology, 2:1–15, American Society of Clinical Oncology, 2018.
bibtex   
@article{piotrowska2018heterogeneity,
  title={Heterogeneity and coexistence of T790M and T790 wild-type resistant subclones drive mixed response to third-generation epidermal growth factor receptor inhibitors in lung cancer},
  author={Piotrowska, Zofia and Hazar-Rethinam, Mehlika and Rizzo, Coleen and Nadres, Brandon and Van Seventer, Emily E and Shahzade, Heather A and Lennes, Inga T and Iafrate, Anthony J and Dias-Santagata, Dora and Leshchiner, Ignaty and others},
  journal={JCO precision oncology},
  volume={2},
  pages={1--15},
  year={2018},
  publisher={American Society of Clinical Oncology}
}

Downloads: 0